Business Description
Exousia Pro Inc
NAICS : 541714
SIC : 2834
ISIN : US36257K2087
Description
Exousia Pro Inc is a exosome-based biotechnology, develops and manufactures mammalian and plant-based exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company is developing new ways to exploit the therapeutic potential of exosomes, initially focused in the field of oncology. The platform technology of the company also helps treating a broad spectrum of viral infections.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 60.39 | |||||
9-Day RSI | 52.86 | |||||
14-Day RSI | 46.75 | |||||
3-1 Month Momentum % | -73.18 | |||||
6-1 Month Momentum % | -78.94 | |||||
12-1 Month Momentum % | -89.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -1.15 | |||||
EV-to-EBITDA | -1.15 | |||||
EV-to-FCF | -150 | |||||
Earnings Yield (Greenblatt) % | -86.96 | |||||
FCF Yield % | -0.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MAJI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Exousia Pro Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.043 | ||
| Beta | -7.0803 | ||
| 3-Year Sharpe Ratio | 0.6 | ||
| 3-Year Sortino Ratio | 1.63 | ||
| Volatility % | 152.76 | ||
| 14-Day RSI | 46.75 | ||
| 14-Day ATR ($) | 0.002254 | ||
| 20-Day SMA ($) | 0.007805 | ||
| 12-1 Month Momentum % | -89.49 | ||
| 52-Week Range ($) | 0.0065 - 0.21 | ||
| Shares Outstanding (Mil) | 68.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Exousia Pro Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Exousia Pro Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-19 | In 138 days | ||
| Second quarter earnings results for 2026 | 2026-08-19 | In 46 days | ||
| General meeting for 2025 | 2026-07-09 | In 5 days | ||
| First quarter earnings results for 2026 | 2026-05-22 | 0.01 (-0.90%) | ||
| Annual report for 2025 | 2026-04-15 | 0.02 (-45.99%) | ||
| Third quarter earnings results for 2025 | 2025-11-19 | 0.06 (+20.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-19 | 0.09 (-7.00%) | ||
| First quarter earnings results for 2025 | 2025-05-20 | 0.18 (-1.11%) | ||
| Annual report for 2024 | 2025-03-24 | 0.07 (+0.00%) | ||
| 0.05:1 Stock Split | 2022-11-15 | 0.17 (+26.87%) |
Show
Entries
Exousia Pro Inc Frequently Asked Questions
What is Exousia Pro Inc(MAJI)'s stock price today?
The current price of MAJI is $0.01. The 52 week high of MAJI is $0.21 and 52 week low is $0.01.
When is next earnings date of Exousia Pro Inc(MAJI)?
The next earnings date of Exousia Pro Inc(MAJI) is 2026-08-19 Est..
Does Exousia Pro Inc(MAJI) pay dividends? If so, how much?
Exousia Pro Inc(MAJI) does not pay dividend.
Guru Commentaries on OTCPK:MAJI
No articles.
Press Release
Articles on Exousia Pro Inc
No articles.